A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy

Annals of Oncology

Volumn 7, Issue 6, 1996, Pages 587-592

  Franzen L ^a   Nyman, J ^b   Hagberg, H ^c   Jakobsson, M ^d   Sorbe, B ^e   Nyth, A L ^f   Lomberg, H ^f   Henriksson, R ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Diarrhoea; Emesis; Fractionated radiotherapy; Ondansetron; Quality of life

Indexed keywords

ONDANSETRON; PLACEBO;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0029795511     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010675     Document Type: Article

References (15)

1. Danjoux CE, Rider WD, Fitzpatric PJ. The acute radiation syndrome. A memorial to William Court-Brown. Clin Radiol 1979; 30: 581-4.
2. Priestman TJ, Priestman S. An initial evaluation of nabilone in the control of radiotherapy-induced nausea and vomiting. Clin Radiol 1984; 35: 265-6.
3. Priestman TJ, Priestman S, Canney PA. A double-blind randomised cross-over comparison of nabilone and methoclopramide in the control of radiation-induced nausea. Clin Radiol 1987; 38: 543-4.
4. Lucraft HH, Palmer MK. Randomised clinical trial of levonan-tradol and chlorpromazine in the prevention of radiotherapy-induced vomiting. Clin Radiol 1982; 33: 621-2.
5. Rawlins MD, Taylor WB, Bateman DN. Rational approaches to therapy for nausea and vomiting. Two common solutions. In Davis, CJ, Lake-Bakaar GV, Grahame-Smith DG (eds): Nausea and Vomiting: Mechanism and Treatment. Berlin, Heidelberg: Springer-Verlag 1986; 167-71.
6. Butler A, Hill JM, Ireland SJ et al. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol 1988; 94: 397-412.
7. Gunning, Hagan RM, Tyers BM. Cisplatin induces biochemical and histological changes in the small intestine of the ferret. Br J Pharmacol 1987; 90:135.
8. Priestman TJ. Clinical studies with ondansetron in the control of radiation-induced emesis. Eur J Cancer Clin Oncol 1989; 25: 829-33.
9. Henriksson R, Lomberg H, Irsaelsson G, Franzén L. The effect of ondansetron on radiation-induced emesis and diarrhoea. Acta Oncol 1992; 31: 767-9.
10. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
11. Bradley JV. Distribution-Free Statistical Test. London: Prentice-Hall Inc. 1968; 78-80.
12. Feyer PC. Incidence of emesis and nausea in fractionated radiotherapy patients. Glaxo Ondansetron Satellite Symposia. Advances in Optimising the Control of Emesis, 20 November 1994, ESMO, Lisbon, Portugal.
13. Priestman TJ, Roberts JT, Upadhyaya BK. A prospective randomised double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. Clin Oncol 1993; 5: 358-63.
14. Sorbe B, Berglind BM, de Bruijin K. Tropisetron, a new 5-HT3 receptor antagonist, in the prevention of radiation-induced emesis. Radiother Oncol 1992; 23(2): 131-2.
15. Prentice HG, Cunningham S, Gandhi L et al. Granisetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 1995; 15(3): 445-8.